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endoscopic instruments have accentuated the effect of
the surgeon’s tremor, making completion of an anasto-
mosis both difficult and time consuming.7 Recent tech-
nological developments have addressed the difficulties
associated with endoscopic CABG.8,9 To overcome the
limitations of traditional endoscopic instruments, robot-
ic systems have been developed to enhance surgical
dexterity. We have used one of these systems to perform
a prospective clinical trial of endoscopic CABG.
The Zeus Robotic Surgical System (Computer
Motion, Inc, Goleta, Calif) consists of 3 major compo-
nents: a surgeon interface device consisting of a video
monitor and 2 instrument handles, a computer con-
troller, and 2 robotic arms (Fig 1). The surgeon manip-
ulates the instrument handles, which are identical to tra-
ditional microsurgical instruments. The computer
controller digitizes the surgeon’s motions and relays the
information in real time to the 2 robotic arms. These
arms are attached to the operating room table and pre-
cisely control the instrument tips that are within the sur-
gical field. A third voice-controlled robotic arm is used
to hold and move the endoscope.
This system has accurately performed CABG in both
cadaveric and in vivo animal studies.10,11 This report
describes the first prospective, single-center clinical
trial to examine the efficacy and safety of robotically
T he use of minimally invasive endoscopic techniqueshas gained widespread acceptance in a variety of
surgical disciplines. However, these techniques have
had little applicability to cardiac surgery. Although
coronary artery bypass grafting (CABG) and valve
replacements have been performed through small thora-
cotomies and limited sternotomies with considerable
success,1-5 an efficient means of performing totally
endoscopic CABG has not been realized. There are
many reasons for this, including the limited accessibili-
ty to the coronary arteries and the technical challenges
of performing microsurgery with traditional endoscop-
ic instruments.6 The length and fixed pivot point of
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assisted endoscopic CABG. All patients underwent
robotically assisted anastomosis of the left internal tho-
racic artery (LITA) to the left anterior descending coro-
nary artery (LAD). Primary outcome measurements
were device-related complications and graft patency at
6 to 8 weeks.
Methods
Patient selection. The Food and Drug Administration
approved a 10-patient pilot study at 1 institution to examine
the safety and efficacy of robotically assisted CABG with the
Zeus Robotic Surgical System by Computer Motion (Goleta,
Calif). It was stipulated that only the LITA-LAD anastomosis
could be performed with the Zeus device. All other vessels
were sewn by hand in the traditional fashion. Moreover, the
procedure had to be performed with cardiopulmonary bypass
(CPB) and cardioplegic arrest. After approval from our insti-
tutional review board, 15 patients were enrolled in the trial.
Informed consent was obtained from each of the study par-
ticipants. Patients were considered eligible if (1) they pos-
sessed angiographic evidence of occlusive (>50% stenosis)
atherosclerotic disease of the LAD, (2) they required elective
or urgent CABG surgery, and (3) they had had no previous
cardiac operations. Exclusion criteria were as follows:
1. Patients over the age of 80 years
2. Patients with an ejection fraction of 40% or less
3. Patients having severe noncardiac conditions
4. Patients having severe peripheral vascular disease
5. Patients having myocardial infarction within 7 days
before the procedure
6. Patients undergoing concomitant surgery, emergency
surgery, or who have had previous thoracic surgery
7. Patients having calcified or diffuse disease in the LAD
coronary artery
8. Patients participating in other investigational device or
drug studies
Five enrolled patients were excluded from participation.
The reasons for exclusion from the study were ejection frac-
tion less than 40% (1 patient), the presence of a diffusely dis-
eased or intramyocardial LAD (2 patients), myocardial
infarction within 7 days of the operation (1 patient), and
intraoperative hemodynamic instability before CPB (1
patient).
Operating room setup and monitoring. The patients
were placed supine on the operating room table, and arte-
rial and venous access was obtained. After induction of
general anesthesia, the 3 robotic arms of the Zeus system
were attached to the operating table (Fig 1, B). The patient
and the robotic arms were then prepared and draped in a ster-
ile fashion. 
LITA harvest and CPB. For the first 9 patients, a standard
median sternotomy was performed and the LITA was taken
down in a traditional manner. The pericardium was opened
and the heart was exposed. The patient was heparinized and
the activated clotting time was maintained above 450 sec-
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Fig 1. A, The Zeus Robotic Surgical System Surgeon Interface Device. This consists of a video monitor and 2
customized instrument handles. The surgeon manipulates the instrument handles. A computer controller digitizes
the surgeon’s motions and relays this information in real time to robotic arms. B, The robotic arms are attached
to the operating room table and precisely control instrument tips that are positioned via ports within the surgical
field. Two arms hold the surgical instruments, and a third arm is used to control the endoscope. 
A B
onds. The ascending aorta and right atrial appendage were
cannulated and CPB was established. The patient was cooled
to 32°C. A cannula was placed in the aortic root for antegrade
administration of cardioplegic solution and a coronary sinus
catheter was placed for retrograde cardioplegia administration. 
In the tenth patient, the LITA was harvested thoracoscopi-
cally through 3 endoscopic ports. The camera port was placed
in the 4th intercostal space at the anterior axillary line and the
2 instrument ports were in the 2nd and 6th intercostal spaces
in the mid axillary line. A small (4 cm) anterior thoracotomy
was made in the 3rd intercostal space. This patient was placed
on CPB with the Heartport system (Heartport, Inc, Redwood
City, Calif).12
Setup of robotic system. The Zeus Robotic Microsurgical
System consisted of 2 robotic arms that were used to manip-
ulate modified endoscopic instruments (Karl Storz, Culver
City, Calif). The arms were attached to the operating table.
The surgeon controlled the instruments by manipulating spe-
cially designed handles at a console (Fig 2). The handles
allowed for 4 full ranges of motion (pan, roll, tilt, and in/out),
as well as grasping. The surgeon’s motions were directly and
precisely translated from the console to the robotic arms by a
computer controller. Custom-designed software allowed for
tremor elimination, as well as motion scaling over a range of
2:1 to 10:1.
Three thoracoscopic ports were used to sew the anastomo-
sis (Fig 3). This port placement was determined from our pre-
vious animal and cadaveric experience13 and was optimal for
the LAD anastomosis in our hands. The 5-mm right instru-
ment port (Endopath, Ethicon, Inc, Somerville, NJ) was in
the midline just below the xiphoid process. The 10-mm cam-
era port (Endopath, Ethicon) was placed approximately 7 cm
lateral to the midline port in the 5th or 6th intercostal space,
depending on the position of the LAD. The 5-mm left instru-
ment port was placed 7 cm lateral to the camera port in the
6th or 7th intercostal space along the anterior axillary line. A
0° endoscope (Karl Storz) was used and attached to a 3-chip
video camera (Tricam SL, Karl Storz) and light source
(Zenon 300, Karl Storz). The endoscope was manipulated
with the Aesop (Computer Motion) voice-controlled robotic
arm. The video was monitored both at the surgeon console
and on a 21-inch monitor at the head of the operating room
table. The specialized instrument tips were inserted into the
ports.
Administration of cardioplegic solution. In those
patients who required grafts in addition to the LITA-LAD
anastomosis, these grafts were performed first by means of
traditional open chest methods. A crossclamp was applied to
the ascending aorta, and cold blood cardioplegic solution was
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Fig 2. An intraoperative photograph of the surgeon perform-
ing robotically assisted endoscopic cardiac surgery. The sur-
geon is seated at the console approximately 5 yards from the
patient. The operating room table can be seen in the back-
ground.
Fig 3. The positioning of the 3 ports used for the endoscopic
anastomosis. A modified subxiphoid approach was used. The
middle port was a 10-mm port for the camera. Two instru-
ments were placed through lateral and medial 5-mm ports.
ICS, Intercostal space.
administered in an antegrade fashion to achieve arrest.
Myocardial temperature was measured in the interventricular
septum and maintained below 15°C. Additional cardioplegic
solution was given as necessary throughout the remainder of the
operation in a retrograde fashion through the coronary sinus.
In the tenth patient, the Heartport Endoclamp device was
used and cardioplegic solution was administered antegradely
into the aortic root. Subsequently, cardioplegic solution was
administered in a retrograde fashion through a percutaneously
placed coronary sinus cannula.
Robotically assisted coronary anastomosis. The heart
was left in situ and was not suspended in a pericardial cradle.
The chest retractor was relaxed to allow a more normal
anatomic position of the chest wall. After cardioplegic arrest,
an arteriotomy was made in the distal LAD. In the last 5
patients, this was done with specialized scissors and the Zeus
system. A continuous end-to-side anastomosis was performed
endoscopically with the robotic instruments. The heel was
sewn first and parachuted down, followed by completion of
the toe of the anastomosis. No manipulation of the heart was
necessary to perform the anastomosis, and visualization of
each stitch through the subxiphoid camera port was excellent.
An assistant held the LITA pedicle through the chest incision
with standard instruments. The running anastomosis was per-
formed with a specially designed 7-cm double-armed 7-0
polytetrafluoroethylene suture.* Motion scaling (2.5:1) was
used for each anastomosis. After completion of the anasto-
mosis, the suture was tied endoscopically. No repair stitches
were required. The clamp on the LITA and the aortic cross-
clamp were removed, and the patient was rewarmed. The
patient was then weaned from CPB. Protamine sulfate was
administered to reverse the heparin, and the chest was closed
in a standard fashion. No patient required inotropic support.
Short-term graft flow. Blood flow through the LITA graft
was measured with a 2.0- to 2.5-mm ultrasonic flow probe
and flowmeter (HT311, Transonic Systems, Inc, Ithaca, NY)
and was recorded with FlowTrace 32 software (Transonic
Systems, Inc). If flow was not judged to be adequate, selec-
tive coronary angiography was performed in the operating
suite. The LITA graft was selectively catheterized via the left
radial artery. An OEC model 9600 digital imaging system
was used to visualize the anastomosis (Omega Electronics
Corporation, Salt Lake City, Utah).
Patient follow-up. During the postoperative period, the
following data were collected: hemodynamic parameters,
chest tube drainage, need for inotropic medications, length of
intensive care unit stay, and length of hospital stay. Eight
weeks after the operation, all patients underwent a second
coronary angiogram of the LITA-LAD anastomosis to assess
graft patency. Follow-up was 100%.
Results
Patient demographics. Ten (n = 10) patients took
part in the study, 6 men and 4 women. The mean age
was 55.8 ± 3.0 years. Ejection fraction averaged 50% ±
4%.
Intraoperative results. The robotic system was
quick and easy to assemble. The average time required
for setup was 14.9 ± 2.1 minutes. No intraoperative
complications related to port placement were encoun-
tered, and there were no mechanical failures of the
robotic system.
The total number of grafts performed was 2.3 ± 0.3
per patient with a mean crossclamp time of 51.1 ± 1.6
minutes. The time required to perform the endoscopic
LITA-LAD anastomosis with the robotic system was
23.6 ± 1.4 minutes (range 18-30 minutes). All anasto-
moses were successfully performed and no repair
stitches were required.
The patient who had a limited thoracotomy and CPB
with a Heartport device had a crossclamp time of 71
minutes and an anastomosis time of 28 minutes.
All patients underwent intraoperative ultrasonic
determination of flow through the LITA graft. Eighty
percent (8/10) of grafts measured were patent and had
excellent diastolic flow. Average graft flow was 31 ± 7
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Fig 4. Angiogram at 8 weeks of a robotically sewn LITA-
LAD graft. Anastomotic site is marked by the arrow. The
angiogram demonstrates a patent anastomosis.
*Gore-Tex suture; registered trademark of W. L. Gore & Associates,
Inc, Flagstaff, Ariz.
mL/min. Two of the 10 grafts had inadequate flow and
were taken down and reconstructed manually. In 1
case, the patient who had a Heartport procedure, an
intraoperative coronary angiogram was performed. The
graft was not visualized. However, the distal anastomo-
sis was probe patent. A tentative diagnosis of graft
spasm was made. In the second case, angiography was
unavailable. Subsequent review of the videotape
revealed a technical error. This case represented a fail-
ure of surgical technique, not of the robotic system.
Conversion to the manual technique was easily accom-
plished in both patients, and all patients left the operat-
ing room with a patent LITA-LAD anastomosis. 
Postoperative course. There was only one postoper-
ative complication. This patient required return to the
operating room the evening of surgery for excessive
mediastinal hemorrhage. The source of hemorrhage
was identified as the lateral trocar insertion site. The
bleeding was stopped successfully with electrocautery.
No other complications were encountered in the
postoperative period. The average length of stay in the
intensive care unit was 1.1 ± 1 days. The average length
of stay in the hospital was 4.1 ± 0.2 days. 
Late follow-up. A 100% late follow-up was
achieved. The mean period of follow-up was 142.1 ±
10.7 days. No late complications occurred. All patients
are presently in New York Heart Association class I. 
Eight weeks after the operation, graft patency was
assessed by a second coronary angiogram. These studies
were all performed at our institution and revealed that
100% (8/8) of the LITA-LAD grafts were patent (Fig 4).
One graft had a 50% stenosis at its insertion site.
Discussion
Minimally invasive surgical techniques have become
more prevalent in the field of cardiac surgery. The
potential benefits of these approaches include de-
creased blood loss, lower complication rates, and
shorter hospital stays.14,15 Early results of beating heart
procedures have demonstrated acceptable graft patency
and minimal morbidity in large series of patients.2,16
However, with conventional techniques, completely
endoscopic CABG has not been possible.
Recently, robotically assisted microsurgery systems
have been introduced to increase the precision of endo-
scopic surgery. These computer-guided systems can
control both surgical instruments8,9 and endoscopic
cameras.17 These systems may help to overcome the
obstacles to endoscopic CABG. Specifically, robotic
instrumentation may provide access to multiple target
vessels and offer the surgeon the ability to operate pre-
cisely in confined spaces. The most significant limita-
tion to the use of traditional endoscopic instruments in
CABG is the lack of precision that results from the
additive effects of instrument length and operator
tremor. Robotic microsurgical systems address this
limitation by filtering high-frequency motions, thus
eliminating tremor. Dexterity is further enhanced
through computer motion-scaling. This allows the sur-
geon to make large, easy-to-perform macroscopic
movements at the console and have these scaled down
by the computer to microscopic movements of the
instrument tip inside the patient. Endoscopic magnifi-
cation of the operative site also improves the accuracy
of suture placement by providing enhanced visualiza-
tion. The magnification is 3 to 4 times higher than that
with traditional surgical loupes.
Finally, the Zeus system incorporates a robotic voice-
controlled arm (Aesop) to control the endoscope. This
eliminates the need for an assistant and has been shown
to improve the stability of the image, reduce camera
clearings, and decrease the operative time during surgi-
cal procedures.17,18 It has been our early experience
that this technology greatly facilitates microsurgery.
Under high magnification, a stable image is absolutely
critical. Moreover, the ability to control the movement
of the Aesop robotic arm by voice effectively gives the
surgeon a third arm. 
In previous animal studies, endoscopic CABG has
been shown to be feasible with acceptable short-term
and long-term graft patency.11,13 The present study ana-
lyzed the short-term outcome of robotically assisted
endoscopic CABG in human subjects. Short-term graft
patency was 80% (8/10). Conversion to manual anasto-
mosis was easily completed in the 2 patients with inad-
equate flow, and all patients left the operating room
with patent LITA-LAD grafts. Graft patency 2 months
after the operation was 100% (8/8) as demonstrated by
angiography. These results demonstrate the feasibility
of endoscopic CABG. More important, no device-relat-
ed complications were observed. Anastomoses can be
performed with robotic assistance with acceptable
short-term results. The operating room time required
for equipment setup was minimal.
The principal shortcoming of this study was that it does
not represent a completely endoscopic approach. Other
CABGs were performed through traditional incisions.
Clearly, a completely endoscopic procedure will be a
greater challenge, but one that appears to be achievable. 
The other parts of endoscopic CABG have been per-
formed without a surgical incision. Heartport technology
allows for CPB without the need for a thoracic inci-
sion.19 Endoscopic LITA harvest is a widely described
procedure20,21 and can be easily performed manually.
The use of an expensive robotic system does not seem
to be warranted for this part of the procedure.
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Therefore we did not perform the LITA harvest with
the robotic system. We did perform a manual endo-
scopic harvest of the LITA in 1 patient. 
On the other hand, prior attempts to perform manual
endoscopic coronary anastomoses have been fraught
with difficulty and have not been clinically feasible.
Robotic assistance does represent an enabling technol-
ogy for this critical part of the procedure. This report
indicates that the most difficult part of the procedure,
the coronary anastomosis, can be performed endoscop-
ically with robotic assistance. Early experience in
Europe by Mohr’s group22 at the University of Leipzig
and Reichenspurner’s group23 in Munich with endo-
scopic CABG also has been positive.
These early results with robotic systems suggest that
a completely endoscopic approach to CABG is feasible
in carefully selected patients. It is our belief that patient
morbidity will be significantly reduced with this
approach. However, further data are needed to support
this hypothesis. It should be possible in human beings to
perform multiple CABGs with an endoscopic approach
and peripheral cannulation. Moreover, preliminary work
in animal models and in the clinical setting suggest that
beating heart approaches are also feasible.24
Our initial clinical experience indicates that robotic
assistance is an enabling technology that allows for the
performance of endoscopic CABG. Only time will tell
whether the extra costs of this system will be justified
by its potential advantages. Further clinical trials are
warranted to explore the potential of this exciting new
technology. 
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